The in vitro and in vivo apoptotic effects of Mahonia oiwakensis on human lung cancer cells

Chemico-Biological Interactions

Volumn 180, Issue 2, 2009, Pages 165-174

  Wong, Bing Sang ^a   Hsiao, Yung Chin ^b   Lin, Ta Wei ^c   Chen, Kuo Shuen ^b   Chen, Pei Ni ^b,d   Kuo, Wu Hsien ^c,d   Chu, Shu Chen ^d   Hsieh, Yih Shou ^b  

^a TIAN SHENG MEMORIAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Apoptosis; Chemoprevention; Mahonia; NSCLC

Indexed keywords

CASPASE; CYTOCHROME C; KI 67 ANTIGEN; MAHONIA OIWAKENSIS EXTRACT; PACLITAXEL; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHROMOSOME CONDENSATION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAHONIA; MAHONIA OIWAKENSIS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG NEOPLASMS; MAHONIA; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PLANT EXTRACTS;

BACTERIA (MICROORGANISMS); MAHONIA; MUS MUSCULUS;

EID: 67349159708     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.02.011     Document Type: Article

References (38)

1. Augustin M., Andrees U., Grimme H., Schopf E., and Simon J. Effects of Mahonia aquifolium ointment on the expression of adhesion, proliferation, and activation markers in the skin of patients with psoriasis. Forsch. Komplementarmed. 6 (1999) 19-21
2. Bernstein S., Donsky H., Gulliver W., Hamilton D., Nobel S., and Norman R. Treatment of mild to moderate psoriasis with Relieva, a Mahonia aquifolium extract-a double-blind, placebo-controlled study. Am. J. Ther. 13 (2006) 121-126
3. Hajnicka V., Kost'alova D., Svecova D., Sochorova R., Fuchsberger N., and Toth J. Effect of Mahonia aquifolium active compounds on interleukin-8 production in the human monocytic cell line THP-1. Planta Med. 68 (2002) 266-268
4. Rackova L., Majekova M., Kost'alova D., and Stefek M. Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium: structural aspects. Bioorg. Med. Chem. 12 (2004) 4709-4715
5. Rohrer U., Kunz E.M., Lenkeit K., Schaffner W., and Meyer J. Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria. Schweiz. Monatsschr. Zahnmed. 117 (2007) 1126-1131
6. Slobodnikova L., Kost'alova D., Labudova D., Kotulova D., and Kettmann V. Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytother. Res. 18 (2004) 674-676
7. Vollekova A., Kost'alova D., Kettmann V., and Toth J. Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids. Phytother. Res. 17 (2003) 834-837
8. Zeng X., Lao B., Dong X., Sun X., Dong Y., Sheng G., and Fu J. Study on anti-influenza effect of alkaloids from roots of Mahonia bealei in vitro. Zhong. Yao. Cai. 26 (2003) 29-30
9. Muller K., and Ziereis K. The antipsoriatic Mahonia aquifolium and its active constituents. I. Pro- and antioxidant properties and inhibition of 5-lipoxygenase. Planta Med. 60 (1994) 421-424
10. Rackova L., Oblozinsky M., Kostalova D., Kettmann V., and Bezakova L. Free radical scavenging activity and lipoxygenase inhibition of Mahonia aquifolium extract and isoquinoline alkaloids. J. Inflamm. (Lond.) 4 (2007) 15
11. Sotnikova R., Kettmann V., Kostalova D., and Taborska E. Relaxant properties of some aporphine alkaloids from Mahonia aquifolium. Methods Find Exp. Clin. Pharmacol. 19 (1997) 589-597
12. Zeng X., Dong Y., Sheng G., Dong X., Sun X., and Fu J. Isolation and structure determination of anti-influenza component from Mahonia bealei. J. Ethnopharmacol. 108 (2006) 317-319
13. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., and Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J. Ethnopharmacol. 66 (1999) 227-233
14. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., and Fujiwara H. Inhibition of activator protein 1 activity by berberine in human hepatoma cells. Planta Med. 65 (1999) 381-383
15. Lin J.P., Yang J.S., Lee J.H., Hsieh W.T., and Chung J.G. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J. Gastroenterol. 12 (2006) 21-28
16. Mantena S.K., Sharma S.D., and Katiyar S.K. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 27 (2006) 2018-2027
17. Mantena S.K., Sharma S.D., and Katiyar S.K. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol. Cancer Ther. 5 (2006) 296-308
18. Lin C.C., Yang J.S., Chen J.T., Fan S., Yu F.S., Yang J.L., Lu C.C., Kao M.C., Huang A.C., Lu H.F., and Chung J.G. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res. 27 (2007) 3371-3378
19. Kuo C.L., Chou C.C., and Yung B.Y. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett. 93 (1995) 193-200
20. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics 2002. CA Cancer J. Clin. 55 (2005) 74-108
21. Zochbauer-Muller S., Gazdar A.F., and Minna J.D. Molecular pathogenesis of lung cancer. Annu. Rev. Physiol. 64 (2002) 681-708
22. Chu S.C., Yang S.F., Liu S.J., Kuo W.H., Chang Y.Z., and Hsieh Y.S. In vitro and in vivo antimetastatic effects of Terminalia catappa L. leaves on lung cancer cells. Food Chem. Toxicol. 45 (2007) 1194-1201
23. Chen P.N., Kuo W.H., Chiang C.L., Chiou H.L., Hsieh Y.S., and Chu S.C. Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression. Chem. Biol. Interact. 163 (2006) 218-229
24. Ho Y.S., Duh J.S., Jeng J.H., Wang Y.J., Liang Y.C., Lin C.H., Tseng C.J., Yu C.F., Chen R.J., and Lin J.K. Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int. J. Cancer 91 (2001) 393-401
25. Chen P.N., Chu S.C., Chiou H.L., Chiang C.L., Yang S.F., and Hsieh Y.S. Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr. Cancer 53 (2005) 232-243
26. Shen S.C., Ko C.H., Tseng S.W., Tsai S.H., and Chen Y.C. Structurally related antitumor effects of flavanones in vitro and in vivo: involvement of caspase 3 activation, p21 gene expression, and reactive oxygen species production. Toxicol. Appl. Pharmacol. 197 (2004) 84-95
27. Yezhelyev M.V., Koehl G., Guba M., Brabletz T., Jauch K.W., Ryan A., Barge A., Green T., Fennell M., and Bruns C.J. Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clin. Cancer Res. 10 (2004) 8028-8036
28. Agarwal M.L., Taylor W.R., Chernov M.V., Chernova O.B., and Stark G.R. The p53 network. J. Biol. Chem. 273 (1998) 1-4
29. Shipman R., Schraml P., Colombi M., Raefle G., Dalquen P., and Ludwig C. Frequent TP53 gene alterations (mutation, allelic loss, nuclear accumulation) in primary non-small cell lung cancer. Eur. J. Cancer 32A (1996) 335-341
30. Katiyar S.K., Meeran S.M., Katiyar N., and Akhtar S. p53 cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol. Carcinogen. 48 (2009) 24-37
31. Gogvadze V., Orrenius S., and Zhivotovsky B. Multiple pathways of cytochrome c release from mitochondria in apoptosis. Biochim. Biophys. Acta 1757 (2006) 639-647
32. Daniel P.T., Wieder T., Sturm I., and Schulze-Osthoff K. The kiss of death: promises and failures of death receptors and ligands in cancer therapy. Leukemia 15 (2001) 1022-1032
33. Cernakova M., Kost'alova D., Kettmann V., Plodova M., Toth J., and Drimal J. Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium. BMC Complement. Altern. Med. 2 (2002) 2
34. Greathouse G.A., and Rigler N.E. Isolation of the alkaloids, berberine and berbamine, from Mahonia swaseyi. Plant Physiol. 15 (1940) 563-564
35. Gulliver W.P., and Donsky H.J. A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis. Am. J. Ther. 12 (2005) 398-406
36. Vollekova A., Kostalova D., and Sochorova R. Isoquinoline alkaloids from Mahonia aquifolium stem bark are active against Malassezia spp. Folia Microbiol. (Praha) 46 (2001) 107-111
37. Stermitz F.R., Beeson T.D., Mueller P.J., Hsiang J., and Lewis K. Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu strictu) species. Biochem. Syst. Ecol. 29 (2001) 793-798
38. Wolfe K.L., and Liu R.H. Structure-activity relationships of flavonoids in the cellular antioxidant activity assay. J. Agric. Food Chem. 56 (2008) 8404-8411